U.N. extends mandate of NATO force in Afghanistan for last time
UNITED NATIONS — The U.N. Security Council voted unanimously on Thursday to extend the mandate of the NATO-led force in Afghanistan for the last time before it hands over total responsibility for security to Afghan forces at the end of 2014.
The resolution adopted by the council said the situation in Afghanistan “still constitutes a threat to international peace and security.”
It expressed serious concern about security in the country, pointing to ongoing violence and terrorist activities by the Taliban, al-Qaida and other illegal and extremist groups as well as by criminals and those involved in the illegal drug trade.
The Taliban have escalated attacks in recent months as they try to take advantage of the withdrawal of foreign troops. In June, Afghan forces took the lead for security nationwide, leaving the NATO-led International Assistance Force known as ISAF entirely in a supporting, backseat role.
ISAF has dropped dramatically in strength as it prepares to leave — down from 130,000 troops two years to just over 87,200 troops on Aug. 1, including 60,000 Americans.
The Security Council extended ISAF's mandate until Dec. 31, 2014, the final day for transferring full security responsibility to the Afghan government.
Its action followed an outburst on Monday from Afghan President Hamid Karzai who alleged that the United States and NATO inflicted suffering on the Afghan people and repeatedly violated its sovereignty. Despite his critical remarks, the Obama administration is still optimistic that a U.S.-Afghan agreement over the future role of American troops in the country can be finalized in the next few weeks.
Karzai made the comments on the 12th anniversary of the start of the American campaign in Afghanistan against al-Qaida that ousted its Taliban allies from power.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.
- Scientists win Nobel chemistry award for work on DNA repair
- Eastern European gangs smuggle nuclear materials, seek terrorist clients
- Russian claims of targeting ISIS in Syria airstrikes disputed
- 3 share Nobel medicine prize for new tools to kill parasites
- 3 share Nobel medicine prize for tropical disease drugs
- Cameron in throes of leave-the-EU movement in Britain
- Afghan charity hospital bombed; Defense Secretary Carter vows full investigation
- Pope urges bishops to reaffirm church’s stance on marriage as synod opens
- Palestinians barred from Old City amid Jewish festival
- NSA leaker Snowden wants to come home to U.S.
- Canadian, Japanese physicists win Nobel for neutrino work